phase 1b studies can be done within a couple months and as soon as their was clinical evidence they are going to market the product. they also stated they were not interested in going the full FDA path. so I'm not too sure why the 5/8 year comment was made...
not 100% clear. also no mention of exploring complementary products as yet?
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Investor Webinar Recording
Ann: AusCann Investor Webinar Recording, page-8
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable